pubmed-article:14755130 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14755130 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:14755130 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:14755130 | lifeskim:mentions | umls-concept:C0178719 | lld:lifeskim |
pubmed-article:14755130 | lifeskim:mentions | umls-concept:C0037083 | lld:lifeskim |
pubmed-article:14755130 | lifeskim:mentions | umls-concept:C0001443 | lld:lifeskim |
pubmed-article:14755130 | lifeskim:mentions | umls-concept:C0391690 | lld:lifeskim |
pubmed-article:14755130 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
pubmed-article:14755130 | lifeskim:mentions | umls-concept:C1948027 | lld:lifeskim |
pubmed-article:14755130 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:14755130 | pubmed:dateCreated | 2004-2-2 | lld:pubmed |
pubmed-article:14755130 | pubmed:abstractText | The growth hormone secretagogue receptor subtype 1a (GHSR-1a) is involved in biological actions of ghrelin by triggering intracellular second messengers coupled to heterotrimeric G-protein complex involving Galpha(q/11). Adenosine is a partial agonist of the GHSR-1a, binding to a binding pocket distinct from the one described for ghrelin. This suggests a variety of functions for the poorly understood GHSR1a receptor. In this work, a sequential analysis of the pathways involved in the regulation of GHSR-1a signaling was undertaken to characterize the intracellular calcium mobilization that is observed following adenosine binding. The results showed that adenosine induced, in a dose-dependent manner, a calcium mobilization from IP(3)-sensitive intracellular stores since the IP(3) receptor blocker 2-APB was able to suppress the calcium response. However, adenosine did not show any effect in the formation of inositol phosphates. The calcium-mobilizing activity was blocked after preincubation of cells with CTX, the inhibitor of adenylate cyclase MDL-12,330A and the protein kinase A blocker H-89. Furthermore, the administration of adenosine stimulated cAMP production. Based on the experimental data, a signaling pathway is proposed involving adenylate cyclase and protein kinase A, which causes phosphorylation of the IP(3) receptor, with a cross-talk between the signaling pathways activated by ghrelin and adenosine. The data described in this report suggest that GHSR-1a is able to activate different intracellular second-messenger systems depending on the agonist that activates it. The regulation of the ghrelin-activated earliest signaling pathways by adenosine may have unexpected implications in the GHSR-1a actions. | lld:pubmed |
pubmed-article:14755130 | pubmed:language | eng | lld:pubmed |
pubmed-article:14755130 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14755130 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14755130 | pubmed:month | Jan | lld:pubmed |
pubmed-article:14755130 | pubmed:issn | 0028-3835 | lld:pubmed |
pubmed-article:14755130 | pubmed:author | pubmed-author:CasanuevaFeli... | lld:pubmed |
pubmed-article:14755130 | pubmed:author | pubmed-author:CamiñaJesus... | lld:pubmed |
pubmed-article:14755130 | pubmed:author | pubmed-author:SmithRoy GRG | lld:pubmed |
pubmed-article:14755130 | pubmed:author | pubmed-author:CarreiraMarco... | lld:pubmed |
pubmed-article:14755130 | pubmed:copyrightInfo | Copyright 2004 S. Karger AG, Basel | lld:pubmed |
pubmed-article:14755130 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14755130 | pubmed:volume | 79 | lld:pubmed |
pubmed-article:14755130 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14755130 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14755130 | pubmed:pagination | 13-25 | lld:pubmed |
pubmed-article:14755130 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:meshHeading | pubmed-meshheading:14755130... | lld:pubmed |
pubmed-article:14755130 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:14755130 | pubmed:articleTitle | Agonist-specific coupling of growth hormone secretagogue receptor type 1a to different intracellular signaling systems. Role of adenosine. | lld:pubmed |
pubmed-article:14755130 | pubmed:affiliation | Department of Medicine, Research Area, Molecular Endocrinology Laboratory, Complejo Hospitalario Universitario de Santiago (CHUS) and University of Santiago de Compostela, Santiago de Compostela, Spain. | lld:pubmed |
pubmed-article:14755130 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14755130 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:14755130 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:2693 | entrezgene:pubmed | pubmed-article:14755130 | lld:entrezgene |